In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
U.K. stocks are slightly down Monday morning, due largely to weakness in the mining sector after data showed a contraction in the ...
The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research & ...
They call themselves Speed to Market, a group of life sciences and real estate professionals who find, build, and sell manufacturing space for biotech employers around Philadelphia. During the COVID ...
A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...
British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...
Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...
Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...
A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...